The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Sofosbuvir/velpatasvir
Australian Public Assessment Report
Device/Product Name
Epclusa
Active ingredients
Sofosbuvir/velpatasvir
AusPAR Date
Published
Sponsor
Submission Number
PM 2020-00171-1-2
Submission Type
Extension of indications
Decision
Approved